Professor Sir Michael Rawlins stated that FDA approval was given if the licensing body had found it was appropriate and therefore it carried weight to the product.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates